Abstract
The last two decade discoveries shift the accent from the consideration of human chorionic gonadotropin (hCG) as a hormone that controls progesterone production by corpus luteum cells to a powerful paracrine regulator that, in the tandem with its hyperglycosylated analog (h-hCG), induces successful implantation and coordinated dialog between blastocyst and uterine tissues. The ability of hCG and h-hCG to interact with TSH receptor and TGF-beta-RII, respectively, significantly extend the spectrum of processes controlled by these molecules. Differences between intracellular pathways of signal transduction between hCG and LH mediated by the same receptor (LH/hCG-R) impugn the unity of their effector mechanisms, which was previously considered as obvious. The paracrine properties of hCG include the control of fusion of trophoblasts into syncytiotrophoblasts, angiogenesis, immunity regulation, and endometrium predisposition to implantation. Angiogenesis is associated with LH/hCG-R expressed on mural cells of uterine spiral arteries as well as induced secretion of soluble VEGF form by endometrial cells. hCG regulates the ratio between different types of T-helper cells in maternal organism at the initial gestation stage determining a high level of Th2 cells. hCG supports local immunotolerance, functioning as a chemoattractant for T-suppressors (T-Treg) and an apoptotic factor for T-lymphocytes. Endometrial susceptibility arises from the activation of osteopantin secretion and the decline of mucin secretion by epithelial cells. h-hCG affects the same tissues as hCG, functioning as a paracrine agent regulating multiple cascades of cytokines. h-hCG plays the key role in the trophoblast invasion into the uterine decidua as a result of gelatinase secretion by these cells. The degree of the angiogenic effect of h-hCG is compatible with that of hCG, but its signal transduction is mediated by the TGF-beta signal transduction pathway that stimulates mural cell proliferation. h-hCG acts as a mitogen on NK-cells and is able to activate them and direct to angiogenesis maintenance. In this article, we attempted to elucidate the most important discoveries about the role of hCG and its hyperglycosylated analog, both accomplished and still upcoming.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Cole, L.A., Biological functions of hCG and hCGrelated molecules, Reprod. Biol. Endocrinol., 2010, vol. 8, no. 1, p. 102.
Stenman, U.-H. and Alfthan, H., Determination of human chorionic gonadotropin, Best Pract. Res., Clin. Endocrinol. Metab., 2013, vol. 27, no. 6, p. 783.
Leao, R. and Esteves, S., Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech, Clinics, 2014, vol. 69, no. 4, p. 279.
Lapthorn, A.J., Harris, D.C., Littlejohn, A., et al., Crystal structure of human chorionic gonadotropin, Nature, 1994, vol. 369, no. 6480, p. 455.
Hershman, J.M., Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid, Best Pract. Res., Clin. Endocrinol. Metab., 2004, vol. 18, no. 2, p. 249.
Birken, S., Kovalevskaya, G., and O’Connor, J., Metabolism of hCG and hLH to multiple urinary forms, Mol. Cell. Endocrinol., 1996, vol. 125, nos. 1–2, pp. 121.
Puett, D., Bhowmick, N., Fernandez, L.M., et al., hCG-receptor binding and transmembrane signaling, Mol. Cell. Endocrinol., 1996, vol. 125, nos. 1–2, pp. 55.
Fournier, T., Guibourdenche, J., and Evain-Brion, D., Review: hCGs: different sources of production, different glycoforms and functions, Placenta, 2015, vol. 36, no. 1, p. 60.
Kamijo, T., Biochemical evidence for autocrine/paracrine regulation of apoptosis in cultured uterine epithelial cells during mouse embryo implantation in vitro, Mol. Hum. Reprod., 1998, vol. 4, no. 10, p. 990.
Cole, L.A., New discoveries on the biology and detection of human chorionic gonadotropin, Reprod. Biol. Endocrinol., 2009, vol. 7, no. 1, p. 8.
Keay, S.D., Vatish, M., Karteris, E., et al., The role of hCG in reproductive medicine, BJOG, 2004, vol. 111, no. 11, p. 1218.
Chatterjee, M., Baliga, B.S., and Munro, H.N., Synthesis of human placental lactogen and human chorionic gonadotropin by polyribosomes and messenger RNA’s from early and full term placentas, J. Biol. Chem., 1976, vol. 251, no. 10, p. 2945.
Gnoth, C. and Johnson, S., Strips of hope: accuracy of home pregnancy tests and new developments, Geburtshilfe Frauenheilkd, 2014, vol. 74, no. 7, p. 661.
Evans, J., Salamonsen, L.A., Menkhorst, E., and Dimitriadis, E., Dynamic changes in hyperglycosylated human chorionic gonadotrophin throughout the first trimester of pregnancy and its role in early placentation, Hum. Reprod., 2015, vol. 30, no. 5, p. 1029.
Handbook of Clinical Laboratory Testing during Pregnancy, Gronowski, A.M., Ed., Springer Sci. & Bus. Media. 2004.
Filmore, D., It’s a GPCR world, Mod. Drug Discovery, 2004, vol. 7, no. 11, p. 24.
Ascoli, M., Fanelli, F., and Segaloff, D.L., The lutropin/ choriogonadotropin receptor, a 2002 perspective, Endocr. Rev., 2013, vol. 23, no. 20, p. 141.
Berndt, S., Blacher, S., Munaut, C., et al., Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-ß receptor activation, FASEB J., 2013, vol. 27, no. 4, p. 1309.
Choi, J. and Smitz, J., Luteinizing hormone and human chorionic gonadotropin: origins of difference, Mol. Cell. Endocrinol., 2014, vol. 383, nos. 1–2, pp. 203.
Davis, J.S., West, L.A., Weakland, L.L., and Farese, R.V., Human chorionic gonadotropin activates the inositol 1,4,5-trisphosphate-Ca 2+ intracellular signalling system in bovine luteal cells, FEBS Lett., 1986, vol. 208, no. 2, p. 287.
Channing, C.P. and Tsafriri, A., Mechanism of action of luteinizing hormone and follicle-stimulating hormone on the ovary in vitro, Metabolism, 1977, vol. 26, no. 4, p. 413.
Tepperman, J., Metabolic and Endocrine Physiology. An Introductory Text, Chicago: Year Book Med. Publ., 1986, 2nd edition.
Sasson, R., Rimon, E., Dantes, A., et al., Gonadotrophin-induced gene regulation in human granulosa cells obtained from IVF patients. Modulation of steroidogenic genes, cytoskeletal genes and genes coding for apoptotic signalling and protein kinases, Mol. Hum. Reprod., 2004, vol. 10, no. 5, p. 299.
Fan, H.-Y., Liu, Z., Shimada, M., et al., MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility, Science, 2009, vol. 324, no. 5929, p. 938.
Islami, D., Modulation of placental vascular endothelial growth factor by leptin and hCG, Mol. Hum. Reprod., 2003, vol. 9, no. 7, p. 395.
Neulen, J., Yan, Z., Raczek, S., et al., Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome, J. Clin. Endocrinol. Metab., 1995, vol. 80, no. 6, p. 1967.
Racicot, K.E., Wünsche, V., Auerbach, B., et al., Human chorionic gonadotropin enhances trophoblastepithelial interaction in an in vitro model of human implantation, Reprod. Sci., 2014, vol. 21, no. 10, p. 1274.
Schumacher, A., Brachwitz, N., Sohr, S., et al., Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy, J. Immunol., 2009, vol. 182, no. 9, p. 5488.
Kayisli, U.A., Selam, B., Guzeloglu-Kayisli, O., et al., Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system, J. Immunol., 2003, vol. 171, no. 5, p. 2305.
Rao, C.V., Potential therapy for rheumatoid arthritis and Sjögren syndrome with human chorionic gonadotropin, Reprod. Sci., 2015, vol. 23, no. 5, p. 566. doi 10.1177/1933719115597765
Giacobbe, A.M., Grasso, R., Triolo, O., et al., Thyroid diseases in pregnancy: a current and controversial topic on diagnosis and treatment over the past 20 years, Arch. Gynecol. Obstet., 2015, vol. 292, no. 5, p. 995.
Arturi, F., Presta, I., Scarpelli, D., et al., Stimulation of iodide uptake by human chorionic gonadotropin in FRTL-5 cells: effects on sodium/iodide symporter gene and protein expression, Eur. J. Endocrinol., 2002, vol. 147, no. 5, p. 655.
Butler, S.A. and Iles, R.K., Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin beta-induced apoptosis in Kaposi’s sarcoma: is there a connection?, Clin. Cancer Res., 2003, vol. 9, no. 13, p. 4666.
Lee-Huang, S., Huang, P.L., Sun, Y., et al., Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin, Proc. Natl. Acad. Sci. U. S. A., 1999, vol. 96, no. 6, p. 2678.
Abdallah, M.A., Lei, Z.M., Li, X., et al., Human fetal nongonadal tissues contain human chorionic gonadotropin/ luteinizing hormone receptors, J. Clin. Endocrinol. Metab., 2004, vol. 89, no. 2, p. 952.
Niebyl, J.R., Nausea and vomiting in pregnancy, N. Engl. J. Med., 2010, vol. 363, no. 16, p. 1544.
Butler, S.A., Ikram, M.S., Mathieu, S., and Iles, R.K., The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation, Br. J. Cancer, 2000, vol. 82, no. 9, p. 1553.
Gregory, J.J. and Finlay, J.L., Alpha-fetoprotein and beta-human chorionic gonadotropin, Drugs, 1999, vol. 57, no. 4, p. 463.
Lijesen, G., Theeuwen, I., Assendelft, W., and Wal, G., The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis, Br. J. Clin. Pharmacol., 1995, vol. 40, no. 3, p. 237.
Solopaeva, I.M. and Ivanova, N.L., New view of the human chorionic gonadotrophin pharmacological activity and its influence on the pathologically changed liver, Sovrem. Tekhnol. Med., 2010, vol. 2, no. 1, p. 12.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M.A. Borisova, D.Yu. Moiseenko, O.V. Smirnova, 2017, published in Fiziologiya Cheloveka, 2017, Vol. 43, No. 1, pp. 97–110.
Rights and permissions
About this article
Cite this article
Borisova, M.A., Moiseenko, D.Y. & Smirnova, O.V. Human chorionic gonadotropin: Unknown about known. Hum Physiol 43, 93–104 (2017). https://doi.org/10.1134/S0362119716060050
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0362119716060050